Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1994-12-30
1997-05-13
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
424 945, 514461, 514975, A61K 4904
Patent
active
056289812
ABSTRACT:
Nanoparticulate crystalline x-ray contrast agents are formulated with stabilizers to enhance contact between the crystalline x-ray contrast agents and the gastrointestinal tract.
Nanoparticulate crystalline therapeutic substances also formulated with stabilizers to enhance contact between the crystalline therapeutic substances and the gastrointestinal tract and to provide extended therapeutic effect.
REFERENCES:
patent: 4107288 (1978-08-01), Oppenheim et al.
patent: 4501726 (1985-02-01), Schroder et al.
patent: 5015452 (1991-05-01), Matijevic
patent: 5118528 (1992-06-01), Fessi et al.
patent: 5145684 (1992-09-01), Liversidge et al.
patent: 5310538 (1994-05-01), Bacon et al.
patent: 5312616 (1994-05-01), Illig et al.
patent: 5318768 (1994-06-01), Illig et al.
patent: 5326552 (1994-07-01), Na et al.
patent: 5326553 (1994-07-01), Illig et al.
patent: 5336484 (1994-08-01), Bacon et al.
patent: 5340564 (1994-08-01), Illig et al.
patent: 5342605 (1994-08-01), Illig
Eickhoff W. Mark
Illig Kathleen J.
Liversidge Gary
Ruddy Stephen B.
Sarpotdar Pramod
Hollinden Gary E.
Nano Systems L.L.C.
LandOfFree
Formulations of oral gastrointestinal diagnostic x-ray contrast does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Formulations of oral gastrointestinal diagnostic x-ray contrast , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulations of oral gastrointestinal diagnostic x-ray contrast will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1383058